Histologically Proven Bronchial Neuroendocrine Tumors in MEN1: A GTE 51‐Case Cohort Study
- 7 August 2017
- journal article
- research article
- Published by Wiley in World Journal of Surgery
- Vol. 42 (1) , 143-152
Abstract
Objective: To evaluate the natural history of MEN1‐related bronchial endocrine tumors (br‐NETs) and to determine their histological characteristics, survival and causes of death. Summary background data: br‐NETs frequency ranges from 3 to 13% and may reach 32% depending on the number of patients evaluated and on the criteria required for diagnosis. Methods: The 1023‐patient series of symptomatic MEN1 patients followed up in a median of 48.7 [35.5–59.6] years by the Groupe d’étude des Tumeurs Endocrines was analyzed using time‐to‐event techniques.Results: br‐NETs were found in 51 patients (4.8%, [95% CI 3.6–6.2%]) and were discovered by imaging in 86% of cases (CT scan, Octreoscan, Chest X‐ray, MRI). Median age at diagnosis was 45 years [28–66]. Histological examination showed 27 (53%) typical carcinoids (TC), 16 (31%) atypical carcinoids (AC), 2 (4%) large cell neuroendocrine carcinomas (LCNEC), 3(6%) small cell neuroendocrine carcinomas (SCLC), 3(6%) TC associated with AC. Overall survival was not different from the rest of the cohort (HR 0.29, [95% CI 0.02–5.14]). AC tended to have a worse prognosis than TC (p = 0.08). Seven deaths were directly related to br‐NETs (three AC, three SCLC and one LCNEC). Patients who underwent surgery survived longer (p = 10−4) and were metastasis free, while 8 of 14 non‐operated patients were metastatic. There were no operative deaths.Conclusions: Around 5% of MEN1 patients develop br‐NETs. br‐NETs do not decrease overall survival in MEN1 patients, but poorly differentiated and aggressive br‐NETs can cause death. br‐NETs must be screened carefully. A biopsy is essential to operate on patients in time.Keywords
This publication has 29 references indexed in Scilit:
- Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d’étude des Tumeurs Endocrines (GTE) cohort studyHuman Molecular Genetics, 2013
- Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort studyThe Lancet, 2012
- Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'étude des Tumeurs EndocrinesEuropean Journal of Endocrinology, 2011
- The pathological diagnosis of neuroendocrine tumors: common questions and tentative answersVirchows Archiv, 2011
- Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variabilityHistopathology, 2010
- Risk Factors and Causes of Death in MEN1 Disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) Cohort Study Among 758 PatientsWorld Journal of Surgery, 2009
- Epidemiology of non‐gastroenteropancreatic (neuro)endocrine tumoursClinical Endocrinology, 2006
- Bronchopulmonary carcinoid in multiple endocrine neoplasia type 1Cancer, 2005
- Prolactinomas in familial multiple endocrine neoplasia syndrome type IThe American Journal of Medicine, 1980
- Duality of Pancreatogenous Peptic UlcerNew England Journal of Medicine, 1968